The South Korean biopharmaceutical company submitted intellectual property protection for its IDC224 subcutaneous injection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results